Headline : MRSA Testing Market size to grow by USD 682.12 million from 2022 to 2027, Driven by the rising staphylococcal infections- Technavio

Read more from the original article on here at www.prnewswire.com.

---

No. of Paragraph 49

NEW YORK, March 27, 2023 /PRNewswire/ -- The MRSA testing market is estimated to grow by USD 682.12 million from 2022 to 2027. The market will be growing at a CAGR of 12.13% during the forecast period. The increasing incidence of staphylococcal infections significantly drives the market growth, although factors such as the shortage of trained professionals may impede the market growth. For comprehensive details on the market size of the historic period(2017 to 2021) and forecast period (2023-2027) - View Sample report

Vendor LandscapeThe MRSA testing market is fragmented; the vendors are competing with competitors and are trying to get a greater market share. The major vendors have well-established economies of scale and market presence and generally rely on positioning, technological advances, and the price of the products - The report provides a full list of key vendors, their strategies, and the latest developments.

The MRSA testing market report includes information on the product launches, sustainability, and prospects of leading vendors, including 3M Co., Abbott Laboratories, ALIFAX Srl, Arlington Scientific Inc., Becton Dickinson and Co., bioMerieux SA, Bio Rad Laboratories Inc., Bruker Corp., Creative Diagnostics, Danaher Corp., DiaSorin Spa, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., GENSPEED Biotech GmbH, OpGen Inc., Puritan Medical Products Co., R Biopharm AG, Sekisui Diagnostics LLC, Uniogen Oy, and ZeptoMetrix LLC.

The market is driven by factors such as the increasing incidence of staphylococcal infections, the introduction of new MRSA diagnostic tests, and the increased adoption of automation and system integration in healthcare. Risk factors related to ha-MRSA and ca-MRSA infections are hindering market growth. The rising incidence of staphylococcal infections is a major factor driving the growth of the global methicillin-resistant staphylococcus aureus (MRSA) testing market. This is because of the emergence of antibiotic-resistant staphylococcal strains, such as MRSA and VRSA. Most staphylococcal infections are known to develop in hospitals and other healthcare settings, such as dialysis centers and nursing homes, due to exposure to open body surfaces.

Read more from the original article on here at www.prnewswire.com.

Related Headlines : MRSA Testing Market size to grow by USD 682.12 million from 2022 to 2027, Driven by the rising staphylococcal infections- Technavio (in Google.com):

Hello, below you have a "Web" tab to read more content and an "Image" tab to get related pictures

Example : Trends, Country, News, Jobs, Scholarships, Investment, Business, Politics, Adverts, Fashion, Events, Technology and more.